Connect with us

Technology

CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine

Published

1 day ago

on

Investment from Sandwater, HealthCap, and Tesi will enhance supply chain, customer support, and R&D

HELSINKI and JACKSONVILLE, Fla., July 6, 2026 /PRNewswire/ — CurifyLabs, a health technology company transforming how personalized medicines are made, today announced the closing of a $14 million Series A funding round. The round was co-led by Sandwater and HealthCap, with participation from Tesi (Finnish Industry Investment Ltd.) and existing investors, including Lifeline Ventures. U.S. customers and employees also participated in the round.

Proceeds will be used to expand U.S. operations, strengthen supply chain infrastructure, enhance customer support, and accelerate product innovation.

CurifyLabs’ Compounding System Solution (CSS) combines proprietary software, GMP-manufactured excipient bases, and advanced 3D printing technology to automate the preparation of personalized medications. With advanced quality control processes built in, the CSS produces tailored doses and dosage forms with greater precision and speed than the manual processes typically used in pharmacies today.

Pharmacies in 21 U.S. states and across Europe use CurifyLabs technology to compound and dispense thousands of doses every day. As the company continues to scale, it will invest in its supply chain to ensure its growing network of pharmacy partners has what it needs, when it needs it.

“Personalized medicine is one of the most important frontiers in healthcare enabling better patient outcomes and is experiencing solid growth. We are enabling more pharmacies to deliver personalized medicine in a safer and more efficient way,” said Morten E. Iversen, partner at Sandwater. “CurifyLabs has built something rare — technology that combines clinical rigor with the speed and precision that busy pharmacy teams depend on. We are excited to support their rapid growth in the U.S. and beyond.”

“We have backed more than 136 life sciences companies over nearly three decades, and what sets the best founders apart is their ability to combine scientific depth with real-world execution,” said Daniel Karsberg, partner at HealthCap. “The CurifyLabs team has done exactly that.”

“CurifyLabs is the kind of company we want to support — innovative, globally ambitious, and built on deep scientific expertise,” said Joni Karsikas, Investment Director at Tesi. “Their growth in the U.S. is further proof that Finnish health technology can compete and win on the world stage.”

“This investment reflects the conviction our partners have in what we’re building,” said Charlotta Topelius, CEO and Founder, CurifyLabs. “We have set a high bar for clinical rigor, product quality, and customer support, and this funding gives us the resources to raise that bar further.”

The funding will support ongoing development of the CurifyLabs platform, including its most recent product, the PharmaPrinter Aurum, which compounds up to nine times faster than manual processes. CurifyLabs’ technology is ISO 13485 certified and designed in compliance with FDA 503A/503B standards for non-sterile compounding.

About CurifyLabs
Founded in 2021, CurifyLabs is transforming how personalized medicines are made. Its Compounding System Solution combines proprietary software, GMP-manufactured excipients, and advanced 3D printing technology to bring consistency, safety, and speed to personalized compounding. The company serves compounding pharmacies across 21 U.S. states, where its technology is used to compound and dispense thousands of doses every day. CurifyLabs partners with pharmacies to help deliver precise, patient-specific therapies efficiently and reliably. For more information, visit curifylabs.com.

About Sandwater
Sandwater invests in the commercialization of deep tech and impact-driven companies addressing critical challenges across energy, resource efficiency, robotics/AI and health. We partner with exceptional founders and we provide conviction, competence and capital. Visit sandwater.com to learn more. We invest from late seed through Series B across the Nordics and Northern Europe.

About HealthCap
HealthCap is a European venture capital firm investing exclusively in life sciences. Founded in 1996 and based in Stockholm and Lausanne, the firm has raised more than €1.5 billion across ten funds and backed more than 36 companies globally.

About Tesi
Tesi (Finnish Industry Investment Ltd.) is a state-owned Finnish investment company investing on market terms in venture capital and private equity funds and directly in growth companies. Tesi’s mission is to develop Finland’s investment market and promote economic growth.

View original content to download multimedia:https://www.prnewswire.com/news-releases/curifylabs-raises-14m-series-a-to-power-the-future-of-personalized-medicine-302818558.html

SOURCE CurifyLabs

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Equifax Announces Earnings Release Date and Conference Call for Second Quarter 2026 Results

Published

48 minutes ago

on

July 7, 2026

By

ATLANTA, July 7, 2026 /PRNewswire/ — Equifax® (NYSE: EFX) will announce its financial results for the second quarter ended June 30, 2026, in a release to be issued on Tuesday, July 21, at 6:30 a.m. Eastern Time (ET).

Equifax will host a conference call at 8:30 a.m. ET on July 21, in which senior management will discuss financial and business results for the quarter. Related presentation materials will be published on investor.equifax.com on July 21 at 6:30 a.m. ET.

Conference Call:
US/Canada: 877-559-1190 / +1 201-389-0916
International: Click here for participant International Toll-Free access numbers

Please dial the appropriate number 5-10 minutes prior to the call to complete registration. Name and affiliation/company are required to join the call.

Webcast:
To view the webcast and slide presentation, please click the link and enter your information to be connected. The link becomes active 15 minutes prior to the scheduled start time.

An audio replay of the conference call will be available on investor.equifax.com beginning on July 22.

ABOUT EQUIFAX INC.
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com.

FOR MORE INFORMATION: 
Molly Clegg for Equifax
molly.clegg@equifax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/equifax-announces-earnings-release-date-and-conference-call-for-second-quarter-2026-results-302818533.html

SOURCE Equifax Inc.

Continue Reading

Technology

RPC, Inc. Announces Date for Second Quarter 2026 Financial Results and Conference Call

Published

48 minutes ago

on

July 7, 2026

By

ATLANTA, July 7, 2026 /PRNewswire/ — RPC, Inc. (NYSE: RES) announced today that it will release its financial results for the second quarter ended June 30, 2026 on Thursday, July 30, 2026, before the market opens. In conjunction with its earnings release, the Company will host a conference call to review the Company’s financial and operating results on Thursday, July 30, 2026, at 9:00 a.m. Eastern Time.

Individuals wishing to participate in the conference call should dial toll-free (833) 461-5787, or +1 (585) 542-9983 for international callers, and use meeting ID number 300 114 924. For interested individuals unable to join by telephone, the call also will be broadcast and archived for 90 days on the Company’s investor website. Interested parties are encouraged to click on the webcast link 10-15 minutes prior to the start of the conference call.

About RPC, Inc.
RPC provides a broad range of specialized oilfield services and equipment primarily to independent and major oilfield companies engaged in the exploration, production and development of oil and gas properties throughout the United States, including the Gulf of America, mid-continent, southwest, Appalachian and Rocky Mountain regions, and in selected international markets. RPC’s investor website can be found on the internet at RPC.net.

For information about RPC, Inc. or this event, please contact:

Joshua Large
Vice President, Corporate Finance and Investor Relations
(404) 321-2152
jlarge@rpc.net

Michael L. Schmit
Chief Financial Officer
(404) 321-2140
irdept@rpc.net

View original content to download multimedia:https://www.prnewswire.com/news-releases/rpc-inc-announces-date-for-second-quarter-2026-financial-results-and-conference-call-302819833.html

SOURCE RPC, Inc.

Continue Reading

Technology

JELD-WEN to Release Second Quarter 2026 Results

Published

48 minutes ago

on

July 7, 2026

By

CHARLOTTE, N.C., July 7, 2026 /PRNewswire/ — JELD-WEN Holding, Inc. (NYSE: JELD), a leading global manufacturer of building products, announced today that it will release second quarter 2026 results after the market close on Monday, August 3, 2026. The company will hold a conference call to discuss the results at 8 a.m. EST on Tuesday, August 4, 2026.

Interested investors and other parties can access the call either via webcast found on the Investor Relations section of the company’s website at investors.JELD-WEN.com, or by dialing 888-596-4144 from the United States or +1-646-968-2525 internationally and using the conference ID 4067832.

For those unable to listen to the live event, a replay will be available on the company’s website approximately two hours following completion of the call.

About JELD-WEN Holding, Inc.
JELD-WEN Holding, Inc. (NYSE: JELD) is a leading global designer, manufacturer and distributor of high-performance interior and exterior doors, windows, and related building products serving the new construction and repair and remodeling sectors. Based in Charlotte, North Carolina, JELD-WEN operates facilities in 14 countries in North America and Europe and employs approximately 13,900 associates dedicated to bringing beauty and security to the spaces that touch our lives. The JELD-WEN family of brands includes JELD-WEN® worldwide, LaCantina® and VPI™ in North America, and Swedoor® and DANA® in Europe. For more information, visit corporate.JELD-WEN.com or follow us on LinkedIn. 

Media Contact:
Sarah Bruner
Senior Director, Enterprise Communications
980-403-4459
SBruner@jeldwen.com

Investor Relations Contact:
James Armstrong
Vice President, Investor Relations
704-612-7560
jarmstrong@jeldwen.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/jeld-wen-to-release-second-quarter-2026-results-302819855.html

SOURCE JELD-WEN Holding, Inc.

Continue Reading

Trending